Owner AdipoGen Incorporation

Convention US 19 December 2008 77/636854

Service Davies Collison Cave

Filing Date 16 June 2009

Class 1 Assays and reagents for use in genetic research; assays for research purposes; biochemical proteins, enzymes and antibodies for scientific and medical research; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, polyclonal and monoclonal antibodies for in vitro scientific or research use; biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; catalysts for chemical and biochemical processes; cells for scientific, laboratory or medical research; chemicals for use in the purification of proteins for in vitro use; diagnostic kits for research and in vitro use consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents to monitor proteins and reagents; diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; diagnostic preparations and reagents for scientific or research use; diagnostic preparations and reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; genetic identity tests comprised of reagents; kit containing pre-packed columns, chemicals, pre-made buffer concentrates, syringes and instructional manual for the purification of proteins for in vitro use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; nucleic acids for laboratory use; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; protein arrays and nucleotide arrays for scientific and medical research; reagent for chemical analyses; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; reagents for scientific or medical research use; reagents for use in scientific apparatus for chemical or biological analysis; stem cells and stem cell reagents for research purposes; testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for laboratory or research use; testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for clinical or medical laboratory use

Class 5 Anti-diabetic pharmaceuticals; anti-diabetic preparations; biochemical preparations for medical or veterinary purposes; biological preparations for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic preparations for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic reagents for medicinal use; diagnostic reagents and contrast media for medical use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for use in the field of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and natural medicinal extracts derived from animal, plant and microorganism sources for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; preparations for detecting genetic predispositions for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for medical use; vaccines